Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | SCN3A | Q9NY46 | 3/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | SCN1A | P35498 | 2/20 | 0.52 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.52 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9168588 | 0.98 | ALDH1A1 (0.57) | ALDH1A1HPGDL3MBTL1MEN1CYP1A2 | |
| Piperazine SCHEMBL11871903 | 0.88 | ALDH1A1 (0.48) | ALDH1A1HPGDL3MBTL1MEN1CYP1A2 | |
| Diethylamine SCHEMBL17477112 | 0.88 | MAPT (0.51) | ALDH1A1HPGDL3MBTL1MEN1CYP1A2 | |
| SCHEMBL3810441 | 0.87 | ALDH1A1 (0.52) | ALDH1A1HPGDL3MBTL1MEN1CYP1A2 | |
| SCHEMBL11424223 | 0.87 | ALDH1A1 (0.68) | ALDH1A1HPGDL3MBTL1MEN1CYP1A2 | |
| SCHEMBL11780327 | 0.87 | POLB (0.65) | ALDH1A1HPGDL3MBTL1MEN1CYP1A2 | |
| SCHEMBL21480120 | 0.86 | ALDH1A1 (0.50) | ALDH1A1HPGDL3MBTL1MEN1CYP1A2 | |
| SCHEMBL2921682 | 0.86 | PDK1 (0.58) | ALDH1A1HPGDL3MBTL1GAA | |
| SCHEMBL9187652 | 0.86 | ALDH1A1 (0.50) | ALDH1A1HPGDL3MBTL1MEN1CYP1A2 | |
| SCHEMBL3598057 | 0.86 | ALDH1A1 (0.50) | ALDH1A1HPGDL3MBTL1MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 283 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025235864-A1 | COATED NEEDLE ADMINISTRATION SYSTEMS | EVOLUS, INC. (US) | 2025-11-13 | — | — | WO | claimed |
| CN-112557569-B | Method for detecting related substances in lidocaine | 南京海纳医药科技股份有限公司 | 2023-04-11 | — | — | CN | claimed |
| CN-114524749-A | N-diethyl acetyl-2, 6-dimethylaniline crystal and preparation method thereof | 遂成药业股份有限公司 | 2022-05-24 | — | — | CN | claimed |
| US-20220096452-A1 | LOCAL ANESTHETIC FOR THE TREATMENT OF NEUROLOGICAL SYMPTOMS RESULTING FROM BRAIN DYSFUNCTIONS | ICM (INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE) (FR) | 2022-03-31 | — | — | US | claimed |
| CN-112557569-A | Method for detecting related substances in lidocaine | 南京海纳医药科技股份有限公司 | 2021-03-26 | — | — | CN | claimed |
| EP-3679010-A1 | CARBONIC ACID ADDUCTS | Jencluster GmbH (DE) | 2020-07-15 | — | — | EP | claimed |
| CN-110461159-A | Fungicidal compositions | SYNGENTA PARTICIPATIONS AG | 2019-11-15 | — | — | CN | claimed |
| EP-2674956-B1 | HIGH THERMAL STABILITY PELLET COMPOSITIONS FOR THERMAL CUTOFF DEVICES AND METHODS FOR MAKING AND USE THEREOF | THERM-O-DISC INCORPORATED (US) | 2018-02-21 | — | — | EP | claimed |
| US-9765020-B2 | Dichlorophenyl-imino compounds and compositions, and methods for the treatment of mucositis | CELLIX BIO PRIVATE LIMITED (IN) | 2017-09-19 | — | — | US | claimed |
| CN-105315170-B | Dimethyl benzene ammonium long-chain compound, preparation, self-assembly structure and application | 四川大学华西医院 | 2017-08-25 | — | — | CN | claimed |
| US-20100137299-A1 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2010-06-03 | — | — | US | claimed |
| WO-2010045251-A2 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS, INC. (CA) | 2010-04-22 | — | — | WO | claimed |
| US-20090246605-A1 | compressed compression spring positioned within a thermal cut-off composition to reduce the void volume inside a bare cell during initial overcharge; protective device for preventing the battery from exploding upon overcharge; improved thermal stability | SAMSUNG SDI CO., LTD. (KR) | 2009-10-01 | — | — | US | claimed |
| EP-1339701-B1 | HETEROARYL ALKYL PIPERAZINE DERIVATIVES AS FATTY ACID OXIDATION INHIBITORS | CV THERAPEUTICS INC (US) | 2007-02-14 | — | — | EP | claimed |
| US-20060275666-A1 | an electrode assembly whose top and bottom ends are blocked by a heat sensitive composition to reduce the void volume inside a bare cell during initial overcharge; preventing exploding and ignition; batteries have improved heat resistance | SANSUMG SDI CO., LTD (KR) | 2006-12-07 | — | — | US | claimed |
| US-6673257-B1 | BLENDS EMPLOYING AT LEAST TWO ORGANIC COMPOUNDS HAVING KNOWN MELT TEMPERATURES, EXHIBIT IMPROVED THERMAL PROPERTIES AND PERFORMANCE CHARACTERISTICS | THERM-O-DISC, INCORPORATED | 2004-01-06 | — | — | US | claimed |
| EP-1326613-A1 | USE OF SUBSTITUTED IMIDAZO 1,2-A]PYRIDINE-, IMIDAZO 1,2-A]PYRIMIDINE AND IMIDAZO 1,2-A]PYRAZINE-3-YL-AMINE DERIVATIVES FOR PRODUCING NOS-INHIBITING MEDICAMENTS | Grünenthal GmbH (DE) | 2003-07-16 | — | — | EP | claimed |
| WO-2002030428-A1 | USE OF SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE-, IMIDAZO[1,2-A]PYRIMIDINE AND IMIDAZO[1,2-A]PYRAZINE-3-YL-AMINE DERIVATIVES FOR PRODUCING NOS-INHIBITING MEDICAMENTS | Grünenthal GmbH (DE) | 2002-04-18 | — | — | WO | claimed |
| US-4801706-A | ANTIARRHYTHMIA HYPOTENSIVE | AMERICAN HOME PRODUCTS CORPORATION (US) | 1989-01-31 | — | — | US | claimed |
| US-4614798-A | IMPROVED YIELD OF INTERMEDIATE USING TETRAHYDROFURAN OR A MIXTURE OF TOLUENE AND N,N-DIMETHYLACETAMIDE AS SOLVENT | VETAMIX (US) | 1986-09-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220096452-A1 | LOCAL ANESTHETIC FOR THE TREATMENT OF NEUROLOGICAL SYMPTOMS RESULTING FROM BRAIN DYSFUNCTIONS | FABP7, ALB, SLC1A2 | ALDH1A1 1989/4885HPGD 4578/4885L3MBTL1 586/4885 |
| US-20100137299-A1 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | TRPV3, TRPV1, TRPC3 | ALDH1A1 1020/4885HPGD 1101/4885L3MBTL1 2721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.